Group 1 - In October, A-share listed companies continued to implement share buyback plans, with companies like Aibijungguang, Jiuan Medical, COSCO Shipping Holdings, Fujilai, and Minsheng Health announcing their second buyback plans of the year, while Zhijiang Biology launched its third buyback plan for the year, indicating a strategic approach to long-term market value management [1] - Jiuan Medical has been actively maintaining its market value through share buybacks, having executed five buyback plans since 2021, with a total expenditure of 2.879 billion yuan (including some transaction costs) and a cumulative repurchase of 94.9214 million shares [1] - As of the end of October, approximately 348 companies that are currently implementing buybacks have disclosed their progress, with around 137 companies meeting the lower limit of their buyback plans, indicating a relatively fast overall pace [1] Group 2 - Midea Group's buyback efforts have exceeded expectations, with a single-month buyback of 2.466 billion yuan in October, marking the second consecutive month of over 2 billion yuan in buybacks, bringing the total for the year close to 10 billion yuan, making it one of the most active companies in the A-share market for buybacks [2] - Other companies with significant buyback amounts in October include GoerTek, Runze Technology, Youngor, Hengrui Medicine, SF Holding, and Chengde Lululemon, with buyback amounts of 430 million yuan, 351 million yuan, 229 million yuan, 220 million yuan, 200 million yuan, and 153 million yuan respectively [2] - Companies with the highest cumulative buyback ratios as of the end of October include Kejie Intelligent, Huamao Technology, Jingxin Pharmaceutical, and Zhezhong Co., with ratios of 6.66%, 6.42%, 5.49%, and 5% respectively [2]
多家公司年内推出两期回购方案,美的集团单月回购再超20亿元!